ROCHE DIAGNOSTICS LIMITED
Location
Founded
1956-09-14
Website
Risk Signals
24752 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Business Services, Not Elsewhere Classified), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about ROCHE DIAGNOSTICS LIMITED
Live alerts from global media, monitored by Business Radar
2025-05-08 (emarketer.com)
Gilead boosts US manufacturing amid Trump administration tariff, HIV healthcare challenges
Gilead joins pharma companies that are boosting US manufacturing amid Trump-induced challenges: Gilead Sciences faces unique challenges as a leading HIV drugmaker—Trump's tariff threats coincide with cuts to global HIV programs and LGBTQ+ healthcare initiatives.
Read more
2025-04-07 (langenthalertagblatt.ch)
Provision against punitive tariffs: Swiss pharmaceutical industry transports as many medication as possible to the USA
Because of Trump's customs threat, the pharmaceutical companies have already made massive products to America and expanded their warehouses. Novartis in particular is said to have made it so.
Read more
2025-03-26 (supplychaindigital.com)
How Roche is Optimising Global Lab Supply Chains With Tecsys | Supply Chain Magazine
Roche selects Tecsys' cloud-based Elite platform to automate inventory across 1,000 labs in more than 50 countries, boosting efficiency and visibility
Read more
2024-09-20 (geneonline.com)
Five Biotech Stocks Soar: Eyes on Halozyme, United Therapeutics, Harmony, Ligand, and ADMA
Biotech stocks surged to a two-year high amid promising clinical developments, with Halozyme, United Therapeutics, Harmony, Ligand, and ADMA.
Read more
2024-09-20 (geneonline.com)
Five Biotech Stocks Soar: Eyes on Halozyme, United Therapeutics, Harmony, Ligand, and ADMA
Biotech stocks surged to a two-year high amid promising clinical developments, with Halozyme, United Therapeutics, Harmony, Ligand, and ADMA.
Read more
2024-09-06 (nicematin.com)
“I have to live with a friend”: in this town of Paillon, mail delivery has been causing a stir for months
Mail problems continue in Drap. In any case, this is what residents of several sectors of this Paillon commune are complaining about. The problem had already been raised in the spring and La Poste had justified it by a reorganization of the sorting center of
Read more
2024-05-07 (massdevice.com)
Enable Injections, Roche expand enFuse delivery partnership
Enable Injections announced that it expanded a collaboration with Roche to utilize its enFuse delivery technology in development programs.
Read more
2024-01-26 (genengnews.com)
GenEdit Tackles "Delivery, Delivery, Delivery" with Up-to-$644M Genentech Collaboration
GenEdit and Genentech launch an up-to-$644 million collaboration to discover and develop novel nanoparticles capable of delivering the Roche subsidiary’s nucleic acid-based treatments for autoimmune disease.
Read more
2023-07-13 (statnews.com)
Roche shortens delivery time for multiple sclerosis drug from hours to minutes in trial
For people living with multiple sclerosis, slowing or stopping the disease often means sitting through hours-long infusion sessions. A new drug could shorten that period dramatically.
Read more
2023-02-13 (bioprocessintl.com)
US FDA again delays Biocon bevacizumab approval on back of 483s
The CRL outlines the need for Biocon Biologics to resolve observations made during facility inspections in August 2022.
Read more
2022-07-06 (fiercepharma.com)
AstraZeneca, GSK and more weathered Q2's economic headwinds, but Roche's stock took a hit: analysts
Blaming the “supply chain” has almost become a punch line—the go-to excuse for explaining any negative performance. | A set of economic headwinds, including the Ukraine War, COVID lockdowns in China, inflation, supply chain problems and the resulting rise in operational costs has led some companies
Read more
2021-03-01 (mobihealthnews.com)
Roche inks deal with Diabeloop to integrate automated insulin delivery
As part of the partnership Roche's Accu-Chek insulin pump can integrate with Diabeloop monitoring system.
Read more